New Drugs for CNS, Endocrine, and Infectious Diseases is organized by Alaska Pharmacists Association (AKPhA) and will be held from Dec 15, 2017 - Dec 15, 2020. This Conference has been approved for a maximum of 1.5 CPE hours.
New drug approvals spiked in 2014 and 2015, with those in 2016 being the lowest in six years. It appears the approval rate rebounded in 2017. More drugs are being channeled through restricted distribution systems and many of the drugs are for rare conditions with few treatment options. While only a limited number of pharmacists will be exposed to some of these newer medications at their practice site, all pharmacists should stay current with new drug and formulation approvals, as well as updates to treatment guidelines that could include these new agents.
At the completion of this activity, the participant will be able to:
• recognize the targeted pathologies for the new drugs discussed in this lesson;
• select the indication(s), pharmacologic action(s), clinical applications, dosing regimens, mode of administration, and availability for each drug;
• list the most relevant adverse effects, warnings, precautions, contraindications, and significant drug-drug or drug-food interactions reported with these medications; and
• list important patient counseling information to convey to patients and/or caregivers.
Additional details will be posted as soon as information is available.
Infectious Disease, Endocrinology